Therapy Areas: Devices
BioCryst wins FDA approval for oral HAE prophylaxis in young children
12 December 2025 - BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX), a US-based biotechnology company focused on treatments for hereditary angioedema (HAE) and other rare diseases, said on Friday that it...
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
8 December 2025 - Diabetes management company ALR Technologies SG Ltd (OTC: ALRTF) announced on Monday that it has completed internal manufacturing testing of its GluCurve Pet CGM, confirming accuracy...
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
5 December 2025 - Dermatology specialist Galderma (SWX:GALD) announced on Friday that its regenerative biostimulator Sculptra has received EU Medical Device Regulation (MDR) certification, extending i...
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system
3 December 2025 - Clinical Laserthermia Systems AB (CLS) (Nasdaq First North Growth Market:CLS-B), a provider of tools for precise tissue ablation using heat generated by laser light, said on Wednesda...
Bonesupport shifts CERAMENT V review to FDA's De Novo pathway
2 December 2025 - Swedish orthobiologics company Bonesupport Holding AB (STO:BONEX) announced on Tuesday that it will move its US market application for CERAMENT V (vancomycin) for bone infection from...
Neola Medical secures US patent for disposable lung monitoring probes
2 December 2025 - Medical technology company Neola Medical AB (NASDAQ First North Growth Market:NEOLA) said on Tuesday that it has been granted a US patent for its disposable probes used with the Neol...